Novo Nordisk reports falling market share and margins; 2026 outlook projects a 5-13% decline in sales and operating profit. Read why NVO stock is a hold.
Matt Webber is an experienced personal finance writer, researcher, and editor. He has published widely on personal finance, marketing, and the impact of technology on contemporary arts and culture.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results